In Canada, Mascoma LLC, a subsidiary of Lallemand Inc., and NextFerm Technologies signed a commercial joint development agreement to expand collaboration into the biofuels category. NextFerm is an Israeli biotech company that produces fermentation-derived ingredients for global food and feed industries. Elzaphan Hotamm VP Global Marketing for NextFerm Technologies told FoodIngredientsFirst, “We are about to […]
In Washington, a coalition of the nation’s leaders in advanced and cellulosic biofuels thanked President Trump for his commitment to the RFS, which “has attracted billions of dollars of investment in first-of-a-kind technologies in the advanced and cellulosic biofuels industry.” They also express concerns about the EPA’s July proposal to reduce White House-approved growth in […]
In Tennessee, Mascoma LLC and the U.S. Department of Energy’s BioEnergy Science Center have developed a revolutionary strain of yeast that could help significantly accelerate the development of biofuels from nonfood plant matter. The approach could provide a pathway to eventual expansion of biofuels production beyond the current output limited to ethanol derived from corn. C5 […]
Using a proprietary consolidated bioprocessing, or CBP, technology platform, Mascoma has developed genetically-modified yeasts and other microorganisms to reduce costs and improve yields in the production of renewable fuels and chemicals. The CBP platform utilizes genetically modified yeast and bacteria to convert cellulosic biomass into high-value end-products in a single step that combines hydrolysis and […]
Digest survey spells “low visibility” for cellulosic biofuels. Beta Renewables rates “best in class”. Dupont rates “most heard of”. Belief is big in “commercial eventually” but far less so for “commercial now”. For 18 out of 20 key cellulosic biofuels technologies, fewer than 10% of biofuels stakeholders report that they have a “through understanding” of the technology, and […]
Using a proprietary consolidated bioprocessing, or CBP, technology platform, Mascoma has developed genetically-modified yeasts and other microorganisms to reduce costs and improve yields in the production of renewable fuels and chemicals. The CBP platform utilizes genetically modified yeast and bacteria to convert cellulosic biomass into high-value end-products in a single step that combines hydrolysis and […]
In New Hampshire, Mascoma announced that its consolidated bioprocessing technology (CBP) has been used to produce over 1 billion gallons of renewable fuel. This achievement is a key commercial milestone for its MGT yeast products including TransFerm and TransFerm Yield+. TransFerm is an advanced bioengineered replacement for conventional fermenting yeast that lowers costs for corn ethanol […]
In New Hampshire, Mascoma has brought on Steve Percy, former chairman and CEO of BP America, and Dan Neslon, former vice president of ExxonMobil, to its broad of directors. The company is currently diversifying membership on its board of directors as the company turns towards commercialization. “We are excited to welcome Steve and Dan to […]
From the leaders in bioenergy and chemicals— the real issues and trends, as seen at ABLC In California, ABLC-Next has concluded for this year, and it is time to continue the review from a convergence of advanced biofuels leadership in R&D, commercialization, policy and finance. That will reconvene at ABLC 2014 — the Advanced Biofuels […]
Advanced biofuels – mirage or reality? In January we wrote: “When these 12 projects open for business (or not) in 2013, you’ll know for sure.” So, what do we know? Advanced, next-generation biofuels are on the march, say the supporters. Next-generation biofuels are a debacle, according to a chorus of skeptics including the editorial page […]
